Menu Search
Equities

Nanexa AB

  • Add to watchlist
  • Add to portfolio
  • Add an alert
40M:FRA

Nanexa AB

Actions
  • Price (EUR)0.318
  • Today's Change-0.008 / -2.30%
  • Shares traded10.00k
  • 1 Year change+175.32%
  • Beta1.1543
Data delayed at least 15 minutes, as of Feb 10 2026 07:07 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Nanexa AB is a Sweden-based company engaged in the drug delivery systems industry. The Company specializes in the nanotechnology and research and development in life science. Its products portfolio is comprised of PharmaShell, a drug delivery system that allows for targeting and dosing of drugs; antifungal coating, a system that protects medical products from the in-growth of fungi; and low-friction coating for peripheral venous catheters.

  • Revenue in SEK (TTM)10.58m
  • Net income in SEK-39.06m
  • Incorporated2010
  • Employees15.00
  • Location
    Nanexa ABVirdings Alle 32BUPPSALA 754 50SwedenSWE
  • Phone+46 18100300
  • Websitehttps://nanexa.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.